Adam Kelliher - Avita Medical Insider

AVMXY -- USA Stock  

USD 1.13  0.01  0.88%

Mr. Adam Kelliher was appointed as Chief Executive Officer of Avita Medical Ltd., with effect from 14 April 2015. Mr. Kelliher is a successful entrepreneur with a strong marketing background and a track record of creating and building life science companies. He previously founded Equateq Limited, a cGMPcertified manufacturer providing superpure fatty acids for the nutritional, pharmaceutical and research sectors which was sold to BASF in 2012. He also started Equazen Limited, a leading omega3 and omega6 supplement company whose lead product, eye q for lipid deficiencies linked to learning conditions, and at sale was marketed in 16 countries. Equazen was sold to Galencia of Switzerland in December, 2007
  CEO Since 2015      
Kelliher received a Master of Arts from the University of Auckland and is a graduate of the Entrepreneurial Development Program at the Massachusetts Institute of Technology, Sloan School of Management.

Management Efficiency

The company has return on total asset (ROA) of (67.44) % which means that it has lost $67.44 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (111.87) % meaning that it generated substantial loss on money invested by shareholders.

Similar Executives

Found 1 records

CEO Since

Satya NadellaMicrosoft Corporation

Entity Summary

Avita Medical Limited, a medical device company, develops and distributes regenerative products for the treatment of a range of wounds, scars, and skin defects in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. It also offers ReGenerCell for chronic wounds and ReNovaCell for pigmentation. Avita Medical operates under Medical Devices classification in USA and traded on OTC Market. It employs 37 people.Avita Medical Limited (AVMXY) is traded on OTC Market in USA. It is located in 28159 Avenue Stanford and employs 37 people.

Avita Medical Limited Leadership Team

Damien McDonald, Non-Executive Director
Lou Panaccio, Chairman of the Board
Stella Sung, IR Officer
Jeremy Cook, Director
Ross Saunders, Vice President - Sales and Marketing
Fiona Wood, Non-Executive Director
Dale Sander, CFO
Louis Drapeau, Non-Executive Director
Lorraine Glover, General Manager of Asia Pacific
William Marshall, VP of Operations and Quality
Matt McNamara, Director
Michael Perry, Director
Suzanne Crowe, Non-Executive Director
Gabriel Chiappini, Company Secretary
Andrew Quick, VP of Research and Technology
Ian Macpherson, Non-Executive Deputy Chairman of the Board
Tim Rooney, Interim CEO
Adam Kelliher, CEO
Troy Barring, COO

Stock Performance Indicators

Did you try this?

Run World Markets Correlation Now

World Markets Correlation

Find global opportunities by holding instruments from different markets
All  Next Launch World Markets Correlation

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Avita Medical and Apple. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Balance Of Power module to check stock momentum by analyzing balance of power indicator and other technical ratios.